These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 7147911)

  • 1. [Adoptive immunity test in the study of immunogenesis of the vaccination process in tick-borne encephalitis and herpes].
    Karpovich LG; Bukovskaia SN; Vorob'eva MS; Davydova AA; Barinskiĭ IF
    Vopr Virusol; 1982; 27(5):90-4. PubMed ID: 7147911
    [No Abstract]   [Full Text] [Related]  

  • 2. [The significance of humoral immunity in post-vaccination resistance of mice to tick-borne encephalitis].
    Nikonova AN; Rozhkova LV; Sokolova ED
    Tr Inst Im Pastera; 1989; 65():84-90. PubMed ID: 2560848
    [No Abstract]   [Full Text] [Related]  

  • 3. Evaluation of tick-borne encephalitis DNA vaccines in monkeys.
    Schmaljohn C; Custer D; VanderZanden L; Spik K; Rossi C; Bray M
    Virology; 1999 Oct; 263(1):166-74. PubMed ID: 10544091
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Humoral and cellular immune response to RNA immunization with flavivirus replicons derived from tick-borne encephalitis virus.
    Aberle JH; Aberle SW; Kofler RM; Mandl CW
    J Virol; 2005 Dec; 79(24):15107-13. PubMed ID: 16306582
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Passive immunization reduces immunity that results from simultaneous active immunization against tick-borne encephalitis virus in a mouse model.
    Kreil TR; Burger I; Attakpah E; Olas K; Eibl MM
    Vaccine; 1998; 16(9-10):955-9. PubMed ID: 9682343
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Comparative study of the viremia in tick-borne encephalitis in immune and nonimmune animals].
    Barinskii IF; Davydova AA; Karpovich LG; Bukovskaia SN
    Vopr Virusol; 1981; (4):434-8. PubMed ID: 7303628
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Active immunization against tick-borne encephalitis in the elderly].
    Biró J; Regius O
    Z Gerontol; 1985; 18(6):337-9. PubMed ID: 3879415
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunisation against tick-borne encephalitis by widely used vaccines: short-term history and current recommendations.
    Beran J
    Clin Microbiol Infect; 2005 May; 11(5):424-6. PubMed ID: 15819877
    [No Abstract]   [Full Text] [Related]  

  • 9. [Laboratory methods of controlling immunogenicity of vaccines against tick-borne encephalitis].
    Sokolova ED
    Tr Inst Im Pastera; 1989; 65():90-8. PubMed ID: 2560849
    [No Abstract]   [Full Text] [Related]  

  • 10. Delayed humoral immunity in a patient with severe tick-borne encephalitis after complete active vaccination.
    Kleiter I; Jilg W; Bogdahn U; Steinbrecher A
    Infection; 2007 Feb; 35(1):26-9. PubMed ID: 17297586
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Genetic immunization against tick-borne encephalitis virus].
    Mitrofanova EE; Bakhvalova VN; Dobrikova EIu; Pap VA; Morozova OV
    Mol Biol (Mosk); 1997; 31(3):403-6. PubMed ID: 9297083
    [No Abstract]   [Full Text] [Related]  

  • 12. [Activity of cytokines in immunization with a vaccine against experimental tick-borne encephalitis].
    Ignat'ev GM; Otrashevskaia EV; Vorob'eva MS
    Vopr Virusol; 2003; 48(2):22-5. PubMed ID: 12924094
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Needle-free jet injection of DNA and protein vaccine of the far-eastern subtype of tick-borne encephalitis virus induces protective immunity in mice.
    Omori-Urabe Y; Yoshii K; Ikawa-Yoshida A; Kariwa H; Takashima I
    Microbiol Immunol; 2011 Dec; 55(12):893-7. PubMed ID: 22004565
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effect of interferon inducers on the development of specific resistance to tick-borne encephalitis].
    Vil'ner LM; Finogenova EV; Tikhomirova-Sidorova NS; Rodin IM; Kropachev VA
    Vopr Virusol; 1976; (1):70-5. PubMed ID: 943889
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Comparative study of inactivated cultured vaccines against tick-borne encephalitis manufactured in Russia and in Austria by the "Immuno" firm].
    Vorob'eva MS; Rasshchepkina MN; Ladyzhenskaia IP; Gorbunov MA; Pavlova LI; Bektimirov TA
    Vopr Virusol; 1996; 41(5):221-4. PubMed ID: 8967069
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Early building up of vaccination protection].
    Rustemeier J
    MMW Fortschr Med; 2016 Jun; 158(11):79. PubMed ID: 27271428
    [No Abstract]   [Full Text] [Related]  

  • 17. [Quantitative indices of the immune status of persons inoculated with different vaccines against tick-borne encephalitis].
    Bukovskaia SN; Vorob'eva MS; Karpovich LG; Shalamberidze TD
    Vopr Virusol; 1983; 28(4):100-3. PubMed ID: 6636697
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Efficiency of coadministration of immunomodulators and vaccine in an experiment on tick-borne encephalitis].
    Barinskiĭ IF; Lazarenko AA; Alimbarova LM; Davydova AA
    Vopr Virusol; 2011; 56(4):45-7. PubMed ID: 21899071
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A synthetic peptide based on the NS1 non-structural protein of tick-borne encephalitis virus induces a protective immune response against fatal encephalitis in an experimental animal model.
    Volpina OM; Volkova TD; Koroev DO; Ivanov VT; Ozherelkov SV; Khoretonenko MV; Vorovitch MF; Stephenson JR; Timofeev AV
    Virus Res; 2005 Sep; 112(1-2):95-9. PubMed ID: 16022903
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Ways of improving vaccine prevention of tick-borne encephalitis].
    Dubov AV; Smorodintsev AA
    Vestn Akad Med Nauk SSSR; 1980; (10):50-4. PubMed ID: 7434916
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.